Filing Details
- Accession Number:
- 0001209191-21-067883
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-03 17:07:48
- Reporting Period:
- 2021-11-01
- Accepted Time:
- 2021-12-03 17:07:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1695580 | Kenneth Krogulski | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-01 | 85 | $2.67 | 179,225 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-02 | 85 | $2.63 | 179,310 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-03 | 85 | $2.71 | 179,395 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-04 | 85 | $2.76 | 179,480 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-05 | 85 | $2.71 | 179,565 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-08 | 85 | $2.95 | 179,650 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-09 | 85 | $3.21 | 179,735 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-10 | 85 | $2.94 | 179,820 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-11 | 85 | $2.83 | 179,905 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-12 | 85 | $2.67 | 179,990 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-15 | 85 | $2.71 | 180,075 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-16 | 85 | $2.66 | 180,160 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-17 | 85 | $2.58 | 180,245 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-18 | 85 | $2.58 | 180,330 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-19 | 85 | $2.55 | 180,415 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-22 | 85 | $2.35 | 180,500 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-23 | 85 | $2.29 | 180,585 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-24 | 150 | $2.31 | 180,735 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-26 | 150 | $2.26 | 180,885 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-29 | 150 | $2.23 | 181,035 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-30 | 150 | $4.61 | 181,185 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
Billionaire Hedge Funds
